Paek SY - Search Results

1

Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials.

Merola JF, Armstrong A, Khattri S, Paek SY, Padilla B, Yue C, Photowala H, Kaplan B, Kristensen LE. Merola JF, et al. Among authors: paek sy. J Dermatolog Treat. 2024 Dec;35(1):2342383. doi: 10.1080/09546634.2024.2342383. Epub 2024 Apr 18. J Dermatolog Treat. 2024. PMID: 38632977 Free article. Clinical Trial.

2

Comprehensive Assessment of the Psoriasis Patient (CAPP): A Report from the GRAPPA 2015 Annual Meeting.

Paek SY, Thompson JM, Qureshi AA, Merola JF, Husni ME. Paek SY, et al. J Rheumatol. 2016 May;43(5):961-4. doi: 10.3899/jrheum.160115. J Rheumatol. 2016. PMID: 27134270

3

Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting.

Kaskas N, Merola JF, Qureshi AA, Paek SY. Kaskas N, et al. Among authors: paek sy. J Rheumatol. 2017 May;44(5):695-696. doi: 10.3899/jrheum.170149. J Rheumatol. 2017. PMID: 28461530

4

BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome.

Zaayman M, Nguyen P, Silfvast-Kaiser A, Frieder J, West C, Tumminello K, Paek SY. Zaayman M, et al. Among authors: paek sy. J Dermatolog Treat. 2022 Jun;33(4):1855-1860. doi: 10.1080/09546634.2021.1939847. Epub 2021 Jun 23. J Dermatolog Treat. 2022. PMID: 34106034 Review.

5

Anti-IL17 therapies for psoriasis.

Silfvast-Kaiser A, Paek SY, Menter A. Silfvast-Kaiser A, et al. Among authors: paek sy. Expert Opin Biol Ther. 2019 Jan;19(1):45-54. doi: 10.1080/14712598.2019.1555235. Epub 2018 Dec 8. Expert Opin Biol Ther. 2019. PMID: 30500317 Review.

6

Emerging biomarkers in psoriatic arthritis.

Paek SY, Han L, Weiland M, Lu CJ, McKinnon K, Zhou L, Lim HW, Elder JT, Mi QS. Paek SY, et al. IUBMB Life. 2015 Dec;67(12):923-927. doi: 10.1002/iub.1453. Epub 2015 Nov 24. IUBMB Life. 2015. PMID: 26602058 Free PMC article. Review.

7

Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences.

Azhar A, Zaayman M, Silfvast-Kaiser A, Kivelevitch D, Menter A, Paek SY. Azhar A, et al. Among authors: paek sy. Dermatol Ther. 2021 Jan;34(1):e14486. doi: 10.1111/dth.14486. Epub 2020 Nov 10. Dermatol Ther. 2021. PMID: 33135231 Review.

8

IL-17 inhibitors for psoriasis.

Paek SY, Frieder J, Kivelevitch D, Menter MA. Paek SY, et al. Semin Cutan Med Surg. 2018 Sep;37(3):148-157. doi: 10.12788/j.sder.2018.051. Semin Cutan Med Surg. 2018. PMID: 30215631 Review.

9

Diet in hidradenitis suppurativa: a review of published and lay literature.

Silfvast-Kaiser A, Youssef R, Paek SY. Silfvast-Kaiser A, et al. Among authors: paek sy. Int J Dermatol. 2019 Nov;58(11):1225-1230. doi: 10.1111/ijd.14465. Epub 2019 Apr 21. Int J Dermatol. 2019. PMID: 31006861 Review.

10

Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas.

Kivelevitch D, Frieder J, Watson I, Paek SY, Menter MA. Kivelevitch D, et al. Among authors: paek sy. Expert Opin Pharmacother. 2018 Apr;19(6):561-575. doi: 10.1080/14656566.2018.1448788. Epub 2018 Mar 22. Expert Opin Pharmacother. 2018. PMID: 29565192 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page